butorphanol has been researched along with Genetic Predisposition in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bielefeld, N; Falk, CS; Ferrone, S; Griewank, K; Heeke, C; Horn, PA; Horn, S; Kloor, M; Lennerz, V; Maltaner, R; Maβen, S; Moll, I; Paschen, A; Real, B; Sabbatino, F; Schadendorf, D; Schilling, B; Sucker, A; Zhao, F | 1 |
Audell, L; Danell, B; Hedhammar, A; Malm, S; Strandberg, E; Swenson, L | 1 |
2 other study(ies) available for butorphanol and Genetic Predisposition
Article | Year |
---|---|
Genetic evolution of T-cell resistance in the course of melanoma progression.
Topics: Alleles; B7 Antigens; beta 2-Microglobulin; Butorphanol; Cell Line, Tumor; Cluster Analysis; Cytokines; Disease Progression; Evolution, Molecular; Gene Expression; Genetic Predisposition to Disease; Histocompatibility Antigens Class I; Humans; Lymphocytes, Tumor-Infiltrating; Melanoma; Mutation; Neoplasm Metastasis; Neoplasm Staging; Phenotype; Polymorphism, Single Nucleotide; T-Lymphocyte Subsets | 2014 |
Impact of sedation method on the diagnosis of hip and elbow dysplasia in Swedish dogs.
Topics: Acepromazine; Age Factors; Animals; Butorphanol; Conscious Sedation; Diagnosis, Differential; Dogs; Female; Genetic Predisposition to Disease; Hip Dysplasia, Canine; Hypnotics and Sedatives; Logistic Models; Male; Mass Screening; Medetomidine; Odds Ratio; Pedigree; Predictive Value of Tests; Sex Factors; Surveys and Questionnaires; Sweden; Xylazine | 2007 |